Keyphrases
Total Knee Arthroplasty
100%
Latent Class Analysis
100%
Post-molar Gestational Trophoblastic Neoplasia
75%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
54%
Lifestyle Behaviors
50%
Non-muscle Invasive Bladder Cancer (NMIBC)
50%
Institutional Analysis
50%
Serum Human Chorionic Gonadotropin
50%
Dynamic Risk Assessment
50%
Binary Outcome
50%
Joint Model
50%
Longitudinal Biomarker
50%
Reed-Sternberg Cells
50%
Poor Graft Function
50%
Physiotherapy Program
50%
Recovery Trajectory
50%
Bladder Cancer Diagnosis
50%
Lifestyle Modification
50%
Early Prediction
50%
Tumor Microenvironment
50%
Pediatric Patients
50%
Hematopoietic Cell Transplantation
50%
Outcome-based
50%
Physical Therapy
50%
Advanced Disease
50%
Prognostic Value
50%
Outcome Prediction
50%
Tumor Volume
50%
Walking Speed
50%
Immunohistochemical Markers
50%
COVID-19
50%
Meta-analysis
50%
Longitudinal Trajectories
50%
Systematic Meta-analysis
50%
Group Studies
50%
Brazil
50%
Classical Hodgkin Lymphoma
50%
Immune Reconstitution
50%
Tumor Research
50%
COVID-19 Pandemic Impact
50%
Methotrexate
50%
Pandemic Impact
50%
Changes in Lifestyle
50%
COVID-19 Pandemic
50%
Pediatric Renal Tumors
50%
Renal Tumor
50%
Speed Trajectory
33%
Nomogram
33%
Performance Prediction
30%
B Cells
29%
Medicine and Dentistry
Hematopoietic Cell
100%
Pediatrics
70%
Transplantation
50%
Meta-Analysis
50%
Cell Transplantation
50%
Systematic Review
50%
Hematopoietic Stem Cell Transplantation
50%
Reed-Sternberg Cell
50%
COVID-19
50%
Non Muscle Invasive Bladder Cancer
50%
Kidney Tumour
50%
Lifestyle Modification
50%
Bladder Cancer Diagnosis
50%
Immune Reconstitution
50%
Latent Class Analysis
50%
Methotrexate
50%
Total Knee Arthroplasty
50%
Tumor Microenvironment
50%
Pediatrics Patient
50%
Chorionic Gonadotropin
50%
Classical Hodgkin Lymphoma
50%
Physiotherapy
50%
Walking Speed
50%
Trophoblastic Disease
50%
Neoplasm
40%
Disease
34%
Cancer Research
30%
B Cell
29%
Timed Up and Go Test
27%
Hazard Ratio
20%
Non-Relapse Mortality
20%
Graft Versus Host Reaction
20%
Patient Referral
20%
Diagnosis
20%
Programmed Death-Ligand 1
20%
Thymus and Activation Regulated Chemokine
20%
Molar Pregnancy
16%
Cytopenia
16%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Clinical Guideline
16%
Patient History of Transplantation
16%
Subgroup Analysis
16%
Cytomegalovirus Infection
16%
Counseling
16%
Mixed Model
15%
CD8 Antigen
12%
Natural Killer Cell
12%
Non Communicable Disease
10%
Pediatric Cancer
10%
Intensive Care
10%
